Beyond Drug Development

Beyond Drug Development is a boutique, Australian-owned contract research organization (CRO) specializing in early-phase drug development. The company provides end-to-end support for biotechnology and pharmaceutical clients, ranging from preclinical consulting and regulatory strategy to the management of Phase 1 and early-phase clinical trials in Australia and New Zealand. The firm leverages the Australian clinical trial environment, which offers advantages such as a streamlined ethics process, access to high-quality clinical research networks, and significant R&D tax incentives. Beyond Drug Development positions itself as an integrated, flexible partner that helps global clients navigate the transition from drug discovery to the clinic.